DSM Dyneema Finalizes Cubic Tech Deal

DSM Dyneema, subsidiary of Dutch chemical producer DSM, has finalized the acquisition of Cubic Tech Corporation, a privately owned company based in Mesa, Arizona in the US.

Cubic Tech specializes in the custom design, development and production of innovative high performance ultra-lightweight flexible laminates and fabrics, most of them based on Dyneema, the ultra-high molecular weight polyethylene (UHMwPE) high-tech fiber invented and manufactured by the DSM offshoot.

The Dutch company said the acquisition reinforces the position of Dyneema fiber as one of the leading brands of ultra-high performance materials and also broadens its portfolio, while providing it with complementary downstream processing technology.

Adding Cubic Tech's technology to DSM Dyneema's expertise in application development, operational excellence and marketing competence will accelerate entry into the performance apparel markets and add important new revenue streams as well as creating access to several new applications and strengthening the company's commitment to sustainability, said Jeff Turner, vice president Strategy at DSM Dyneema.

Cubic Tech will be fully integrated into the DSM organization and all employees will be offered transfers.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.